INTRODUCTION
Pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage. 1 Relief from some type of pain is the most frequent indication of any kind of surgery. A large majority of the patients who seek medical attention and subsequently undergo surgical operation do so because of the compelling influence of pain. It is paradoxical that a surgeon, in accomplishing his or her mission of relieving pre-operative pain, induces pain in the early postoperative period which, usually, is much more severe than the original complaint.
Pain, an important cause of post-operative complications, results in poor mobility, increased arterial pressure and myocardial work which may result in increased morbidity or mortality following surgery. urinary retention, haemodynamic and respiratory disturbances as compared to minimal side effects by NSAIDS. Diclofenac is one of the most commonly used NSAID. Oral administration is the route of choice in daily practice but it becomes impractical before and after surgery because of high first pass metabolism and sometimes inability of patient to take it. Its parenteral preparation is irritating and hence it is very painful at the site of administration. Development of skin, subcutaneous and even muscle tissue necrosis (Nicolau syndrome), abscess formation, etc. are rare but serious complications of intramuscular injections of NSAIDS. 3 As the understanding of pain pathophysiology and treatment is increasing, new routes of drug delivery are being discovered with the objective of attempting to block pain at peripheral sites, with maximum active drug and minimal systemic effects. Topical (Transdermal) preparations are the result of such exploration, which are expected to be free of the drawbacks of oral, parenteral diclofenac. Administration is also very simple, noninvasive and only once in 24 hrs.
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Transdermal patch
Composition
Components of a transdermal diclofenac delivery system are:
1. release liner-protects the patch during storage and is removed before its use; 2. drug-drug solution in direct contact with the release liner; 3. adhesive-adheres the components of the patch together and sticks the patch to the skin; 4. membrane-controls the release of the drug from reservoir and multi-layer patches; 5. backing laminates-protects the patch from the environment; 6. Permeation enhancers.
Diclofenac patch has been in use for a long time now. Predel et al group used diclofenac patch for acute traumatic blunt soft tissue injuries and they found that the diclofenac patch was effective, well tolerated and reported no significant adverse events with it when compared to placebo. 6 Allesandri et al in their study on one hundred twenty patients requiring laparoscopic surgery for gynaecologic benign diseases found that the rate of discharge in patients receiving diclofenac patch was comparable to patients receiving standard analgesia. 7 Lionberger and Brennan in 2010 studied the efficacy of diclofenac patch in treating pain due to soft tissue injury and found that topical NSAID is clinically effective in treating acute pain due to soft tissue injuries, producing clinical benefits within several hours of the first application and significant pain relief relative to placebo. 
Exclusion criteria
1.
Pregnant women 2.
Mentally confused or mentally handicapped patients 3.
History of allergy to drug 4.
Severe kidney disease 5.
Patients with neuropathies or nerve injuries 6.
Patients with pain due to cause, other than presenting disease 7.
Age <10 years and >70 years
Assessment
The selected patients were examined, thoroughly investigated and explained about the interpretation of visual linear analogue scale to determine the level of pain during the postoperative period. This was carried out with a 10 cm line marked on paper. The end marked with zero
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International Quantitative measurement of pain was done on visual linear analogue scale at:
1. Immediately after extubation 2.
4 hours after operation 3.
8 hours after operation 4. 12 hours after operation 5.
24 hours after operation
In addition to recordings of Pain score; pulse rate, blood pressure, respiratory rate & temperature, were considered. Besides this, the timing of the rescue analgesia (VAS score >5) in the form of additional dose or additional other analgesic required was also noted.
RESULTS
For better comparison the number of patients of a particular operation was kept same in both the groups.
The age and sex difference was also not significant in the two groups. The mean age in group A was 46.46±12.413 and Group B was 46.30±12.329 years with p = 0.949. Duration of surgery was comparable in the two groups with no significant difference.
Pain was assessed on VAS and was found that pain scores in both the groups were at their peak at or around 8 hours. Mean time of first supplement dose requirement in group A was 7.21 hours and in group B was 7.43 hours. The p value calculated came out to be 0.128 which is non-significant (Table 1 and 2).
So both diclofenac patch and diclofenac injection have same analgesic efficacy with diclofenac patch being advantageous over injection group in having lesser skin side effects, only in 2% of the patients as compared to 14% in injection group (Table 3 ) (Figure 3 and 4). 
DISCUSSION
With the increase in understanding of pain pathophysiology and treatment, new routes of drug delivery are being discovered with the objective of blocking pain at peripheral sites, with maximum active drug and minimal systemic effects. Topical preparations are the result of such exploration. 2) Narcotics or NSAIDS patches: E.g. fentanyl, Buprenorphine and diclofenac patch.
In this study two modes of diclofenac analgesia i.e. transdermal and intramuscular were compared. A total of 100 patients were divided into two groups of 50 patients each. The parameters recorded postoperatively were; Pulse Rate, Blood Pressure, Respiratory Rate, Temperature, and Intensity of pain on VAS(visual analogue scale) at 0, 4, 8, 12, 24hrs. Score of 5 or more on VAS was considered to represent the need of rescue analgesia (tramadol 2mg/kg).The mean time at which first rescue analgesia admixture in study group was 7hr 21min and in control group was 7hr 43min which is comparable. Study group (patch) offered advantage over control in being almost free of deleterious local side effects like skin erythema, pruritus, oedema, abscess, necrosis, etc. and secondly patch is easy to use as compared to injection. These results of the present study are comparable to the studies performed earlier by many workers in terms of efficacy and side effects of diclofenac patch. Lin fen Hsieh et al studied the efficacy and side effects of diclofenac patch in treatment of patients with myofascial pain syndrome of trapezius. 9 In this study diclofenac sodium patches were compared with control menthol patches in randomized, double blind, placebo-controlled trial and the treatment to control ratio was 2:1. Efficacy and safety parameters were assessed before the patch was applied (day 0), three days (day 4) and seven days after (day 8).The findings in this study demonstrated that treatment with diclofenac patch produced significantly greater pain reduction and earlier mobilization of involved muscles than similar treatment with a control menthol patch and the most frequently observed adverse effects in either group was skin irritation and erythema: with 16%-18% in the control group and 3%-6% in the treatment group. So in overall diclofenac sodium patch was superior to placebo in terms of reducing VAS scores and improving functional outcomes, and did not cause significant adverse effects.
Krishna and Natraj conducted a study on 60 patients, randomly divided into two groups of 30 each to compare the efficacy of single dose of diclofenac patch with diclofenac injection as a pre emptive post-operative analgesia.
10 Diclofenac patch 100mg was applied at the start of surgery in study group and diclofenac injection 75mg was given intramuscularly half an hour before the end of surgery in control group. The pain was assessed postoperatively at 2, 6 and 12 hrs postoperatively on VAS. The study ended when patients asked for rescue analgesia or VAS >5. The mean duration of analgesia in control group (injection group) was 7hr 28min and the study group was 8hr 6min (patch group) which was comparable.
The various studies support our study in terms of efficacy and side effects of transdermal patch. Only thing of concern is its slow onset of action after application, so it has to be applied in anticipation to pain and not after the pain sets in. The other minor problem that we faced during the study was poor adhesiveness. The patch would loosen and peel off when applied in summers (due to sweating) or to loose mobile skin parts of the body such as arms or gluteal region. So from the above discussion it is clear that Diclofenac sodium patch is as efficient as Diclofenac sodium intramuscular injection in terms of analgesia when applied timely. Patch being advantageous over injection in having lesser local side effects likes skin erythema, pruritus, oedema, abscess and necrosis. In addition, transdermal systems are non-invasive and can be self-administered. They also improve patient compliance and are generally inexpensive. It is also an option in patients who are unable to swallow oral medications or in whom oral route is to be avoided due to GIT pathologies.
CONCLUSION
Diclofenac sodium patch is better than Diclofenac sodium intramuscular injection in providing postoperative analgesia because efficacy wise both give equivalent results but patch has following additional advantages over the injectable diclofenac :-1) Self administration and self termination. 2) Having lesser local side effects like skin erythema, pruritus, oedema, abscess and necrosis. 3) Drugs avoid first pass metabolism in the liver as drugs enter the systemic circulation directly 4) Useful when patients cannot swallow. 5) Useful even before and after surgery. 6) Useful even if the patient is nauseous or vomiting. Only concern about patch is that it has longer onset of action, so if applied by proper planning this disadvantage can be overcome. Inspite of so many advantages being offered by patch, its use in routine practice is not so common. Probably it is due to lack of awareness and a mental inertia to accept a new concept among medical professionals. This issue needs to be addressed by continuous usage of it by the people who are familiar with its use and popularising it among others.
Precautions
1) Do not apply more or fewer patches or apply patches more often than prescribed by your doctor. 2) Do not apply diclofenac patches to skin that is broken, damaged, cut, infected, or covered by a rash. 3) Do not wear a patch while bathing or showering.
Plan to bath or shower after you remove a patch and before you apply the next patch. 4) Do not apply to hairy skin.
